Anti Human Interleukin-1 Receptor Accessory Protein (IL1 RAP) Antibodies and Uses Thereof

The present invention provides an antibody or an antigen-binding fragment thereof with binding specificity for human interleukin-1 receptor accessory protein (IL1RAP) wherein the antibody or antigen-binding fragment is capable of inhibiting the binding of antibody 'CAN04' to human IL1RAP....

Full description

Saved in:
Bibliographic Details
Main Authors Malmborg Hager, Cecilia Ann-Christin, Von Wachenfeldt, Karin, Sjöström, Kjell, Järås, Marcus, Fioretos, Thoas, Ågerstam, Helena, Svedberg, Agneta
Format Patent
LanguageEnglish
Published 29.10.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides an antibody or an antigen-binding fragment thereof with binding specificity for human interleukin-1 receptor accessory protein (IL1RAP) wherein the antibody or antigen-binding fragment is capable of inhibiting the binding of antibody 'CAN04' to human IL1RAP. The invention further provides the use of such antibodies or an antigen-binding fragments in the treatment and/or diagnosis of IL-1 associated diseases and conditions, including cancers such as acute myeloid leukemia and melanoma.
Bibliography:Application Number: US202016930631